News Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-05-18 EDT			Pre-market 02:13:49
74.34 ^EUR	+0.51%		74.75	+0.55%

12:29am	French and Benelux stocks-Factors to watch	RE
05-18	Sanofi's rare lung disease drug outperforms standard care in trial	RE

All News

Mentions Relevance

05-18	Sanofi's rare lung disease drug outperforms standard care in trial	RE
05-18	Sanofi says rare lung disease drug outperforms standard care in trial	RE
05-18	ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD	GL
05-14	Finance: Why the rich get the best deals
05-14	Finance: Why we only lend to the wealthy
05-08	Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated	MT
05-06	Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports	RE
05-06	Sanofi supports AlphaDetect to accelerate detection of Alpha-1	RE
05-06	Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review - Stat News	RE
05-05	SANOFI : JP Morgan sticks Neutral	ZD
05-05	Sanofi expands its footprint in Canada
05-04	For final dividend	FA
05-04	Sanofi Plans $216 Million AI Center Expansion in Toronto	MT
05-04	Sanofi invests $294M to expand AI center of excellence in Toronto	RE
05-04	Sanofi Expands Artificial Intelligence Center of Excellence in Toronto	CI
05-04	Morgan Stanley Downgrades Sanofi to Equalweight From Overweight, Adjusts Price Target to $52 From $55	MT
04-30	Regeneron's Eylea Franchise on 'Solid Footing' Despite HD Sales Miss in Q1, Oppenheimer Says	MT
04-29	Regeneron beats quarterly estimates on Dupixent demand; shares fall on Eylea weakness	RE
04-29	Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi	GL
04-29	Sanofi Approves Ordinary Annual Dividend, Payable on May 7, 2026	CI
04-29	Sanofi Announces Board and Committee Changes	CI
04-29	Regeneron beats quarterly results estimates on strong Dupixent demand	RE
04-28	Sanofi remains flat despite positive outlook from Oddo BHF
04-28	SANOFI : Bernstein reiterates its Buy rating	ZD
04-28	SANOFI : Buy rating from Deutsche Bank	ZD